Treatment of Headache with Kumkuma Nasal drop and Go-ghrita Nasal drop

A Comparative Study on the efficacy of Kumkuma Nasya and Go-ghrita Nasya in the Management of Ardhavabhedaka w.s.r. to Migraine

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017208

Enrollment

Registered

2019-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Migraine

Interventions

Intervention1: Kumkuma nasya: For nasal drops 8drops in each nostril for 27 days in 3 course of 7days with a gap of 3days between each course Control Intervention1: Go ghruta nasya: For nasal drops 8d

Eligibility

Inclusion criteria

Inclusion criteria: Patient with symptoms of ardhavabhedak(migraine)

Exclusion criteria

Exclusion criteria: Patient under other treatment modalities Patient suffering from hypertension copd and other systemic disease Patient suffering from sinusitis and other secondary type of headache like meningitis brain tumor encephalitis cervical spondylitis referred pain refractive errors and glaucoma Patient contra indicated for nasya

Design outcomes

Primary

Measure	Time frame
Pain reduction episode reduction in migraineTimepoint: 15days	—

Secondary

Measure	Time frame
Stress releifTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr Devdatt S Dave

Parul Ayurvedic hospital

drdsdave54@gmail.com8866841568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026